These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32506206)

  • 21. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
    Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
    Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal monoclonal immunoglobulin deposition disease: the disease spectrum.
    Lin J; Markowitz GS; Valeri AM; Kambham N; Sherman WH; Appel GB; D'Agati VD
    J Am Soc Nephrol; 2001 Jul; 12(7):1482-1492. PubMed ID: 11423577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trifecta of light chain cast nephropathy, monoclonal plasma cell infiltrates, and light chain proximal tubulopathy.
    Koratala A; Ejaz AA; Hiser WM; Clapp WL
    Kidney Int; 2017 Dec; 92(6):1559. PubMed ID: 29153147
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
    Mohan M; Buros A; Mathur P; Gokden N; Singh M; Susanibar S; Jo Kamimoto J; Hoque S; Radhakrishnan M; Matin A; Davis C; Grazziutti M; Thanendrarajan S; van Rhee F; Zangari M; Davies F; Morgan G; Epstein J; Barlogie B; Schinke C
    Am J Hematol; 2017 Aug; 92(8):739-745. PubMed ID: 28383130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
    Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
    Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum free light-chain assay for nonsecretory multiple myeloma with light chain cast nephropathy and light chain deposition disease].
    Honma R; Fukase S; Suzuki M; Omoto E
    Rinsho Ketsueki; 2010 Apr; 51(4):270-4. PubMed ID: 20467224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.
    Hutchison CA; Cockwell P; Moroz V; Bradwell AR; Fifer L; Gillmore JD; Jesky MD; Storr M; Wessels J; Winearls CG; Weisel K; Heyne N; Cook M
    Lancet Haematol; 2019 Apr; 6(4):e217-e228. PubMed ID: 30872075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light chain deposition disease and proximal tubulopathy in two successive kidney allografts.
    Drieux F; Loron MC; Francois A; Bertrand D; Etienne I; Bender S; Godin M; Guerrot D
    Clin Nephrol; 2015 Jun; 83(6):351-6. PubMed ID: 25492671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated light chain deposition disease neuropathy in a patient with multiple myeloma.
    Romano A; Riso V; Bisogni G; Di Paolantonio A; Rossi E; Sabatelli M; Servidei S; Luigetti M
    Amyloid; 2020 Mar; 27(1):67-68. PubMed ID: 31566029
    [No Abstract]   [Full Text] [Related]  

  • 31. Myeloma-related kidney disease.
    Leung N; Nasr SH
    Adv Chronic Kidney Dis; 2014 Jan; 21(1):36-47. PubMed ID: 24359985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Renal failure in multiple myeloma and its treatment].
    Ryšavá R
    Vnitr Lek; 2020; 66(7):425-431. PubMed ID: 33380121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal lesions in multiple myeloma: their relationship to associated protein abnormalities.
    Hill GS; Morel-Maroger L; Méry JP; Brouet JC; Mignon F
    Am J Kidney Dis; 1983 Jan; 2(4):423-38. PubMed ID: 6823960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.
    Zand L; Nasr SH; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Kumar S; Kyle RA; Fervenza FC; Sethi S; Dingli D; Rajkumar SV; Kapoor P; McCurdy A; Leung N
    Leuk Lymphoma; 2015; 56(12):3357-64. PubMed ID: 25860232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous tubular and glomerular involvement with cryoglobulinemia vasculitis in multiple myeloma.
    Zahir Z; Agrawal V; Wani AS; Prasad N
    Saudi J Kidney Dis Transpl; 2019; 30(6):1470-1474. PubMed ID: 31929299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.
    Sethi S; Rajkumar SV; D'Agati VD
    J Am Soc Nephrol; 2018 Jul; 29(7):1810-1823. PubMed ID: 29703839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease.
    Lorenz EC; Sethi S; Poshusta TL; Ramirez-Alvarado M; Kumar S; Lager DJ; Fervenza FC; Leung N
    Nephrol Dial Transplant; 2010 Apr; 25(4):1340-3. PubMed ID: 20061318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic and proteomic characteristics of intratubular cytoplasmic AL amyloidosis.
    Javaugue V; Rocha AB; Said SM; Santoriello D; Hou J; Dasari S; Theis JD; Vrana JA; Batal I; Larsen C; Markowitz GS; D'Agati VD; McPhail ED; Leung N; Nasr SH
    Kidney Int; 2022 Oct; 102(4):926-929. PubMed ID: 35964797
    [No Abstract]   [Full Text] [Related]  

  • 40. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.